CA-INGRAM-MICRO
8.6.2021 19:06:08 CEST | Business Wire | Press release
Ingram Micro Inc. ’s multi-million-dollar investments within its global Advanced Solutions organization are resulting in new and innovative business resources, opportunities, services and solutions for IT channel partners in more than 122 countries. As part of its efforts, the industry leader is also continuing to modernize its processes and systems enabling channel partners to benefit from and provide a more exceptional customer experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210608005190/en/
“Our global Advanced Solutions organization continues to give our channel partners a clear advantage in the markets they serve locally and globally,” says Paul Bay, executive vice president and president, Global Technology Solutions, Ingram Micro. “We’re continuing to invest in and serve as a business partner to solution providers, as well as Managed Services and cloud providers, giving them more innovative ways to run their businesses better, grow markets faster and do more for their customers. We’ve also made it easier for technology manufacturers, cloud and software companies to have an efficient, high impact sales channel with multiple routes to market worldwide.”
Ingram Micro’s Advanced Solutions is a worldwide organization anchored by eight global Centers of Excellence (COEs) and thousands of specialists and solutions architects spanning 122 countries. The worldwide business engages with more than 180 emerging and established vendor partners and operates throughout Asia Pacific (APAC), North America, Latin America, Europe, Middle East and Africa (EMEA).
Over the last three years, Ingram Micro’s Advanced Solutions organization enabled thousands of midsized and small business channel partners to offer a variety of technology solutions including Artificial Intelligence, Cloud, Data Center, IoT, Security and UCaaS technologies. And, within the last 18 months, the organization has achieved major milestones including:
- Established an innovative Ingram Micro Financial Solutions’ global team ready to design ways to boost cashflow by allowing businesses to buy cloud and consumption licenses together with technology product to consume technology as an operating expense, and an agile credit organization granting auto-credit increases for loyal Ingram Micro channel partners.
- A custom program for new and emerging manufacturers or providers of enterprise-grade technology solutions and services, such as its most recent global announcement with UiPath
- Record growth of nearly 30% with Cybersecurity solutions from more than 80 providers and IT channel ecosystem partners, including the industry’s most valuable Cybersecurity companies , and groundbreaking Ingram Micro software solutions currently under pilot in EMEA.
- Additions to the Business Transformation Centers in Buffalo, NY and recently launched Center in Singapore, showcasing exclusive Ingram Micro-bundled Advanced Solutions, which include in-house consultative professional experts and services, in addition to proof-of-concept demonstrations for business decision-makers.
- Debut of the UCC Center of Excellence in EMEA, which served as a lifeline for channel partners across EMEA supplying Unified Communications and UCaaS during the pandemic.
- Expanded Data Center Managed and Professional Services, which give channel partners an easier way to market, sell and support a full solution stack on premise, hybrid and in the cloud.
- Launch of Ingram Micro’s IoT Innovation Lab and Virtual Experience team based in Irvine, CA, providing a fast-track to IoT solutions adopted by local governments, healthcare, and manufacturing.
- Dozens of industry accolades locally, regionally and globally for its excellence in execution including Distributor of the Year and Partner of the Year in 2020 and 2021 .
“Last quarter we had a number of strategic vendors sign new agreements in Latin America, North America and APAC to ensure channel partners have an expert level of support for their solutions,” says Advanced Solutions leader Sabine Howest, vice president, Global Partner Engagement and IoT, Ingram Micro.
Additionally, new investments are being made to enhance Ingram Micro’s expertise across the board and in specific categories including robotics and automation, as well as IoT and Artificial Intelligence.
“We’re assembling an ecosystem of valuable partnerships, combined with experts only Ingram Micro can provide to make it easier for our channel partners to go-to-market in a more agile way with modern technology solutions,” says Howest. “More and more channel partners and providers are using our COEs to build unique, global go-to-market teams and alliances to support their solutions and services. 2020 brought us closer to our partners and providers, together we grew stronger and accomplished more than we ever imagined. This year we’ve set the bar high to invest in our partners and give them an even stronger advantage.”
For more information, Ingram Micro channel partners are encouraged to connect with their sales representatives. Click here to learn more about Ingram Micro Advanced Solutions.
About Ingram Micro
Ingram Micro helps businesses realize the promise of technology. It delivers a full spectrum of global technology and supply chain services to businesses around the world. Deep expertise in technology solutions, mobility, cloud, and supply chain solutions enables business partners to operate efficiently and successfully in the markets they serve. Unrivaled agility, deep market insights and the trust and dependability that come from decades of proven relationships set Ingram Micro apart and ahead. Discover how Ingram Micro can help you realize the promise of technology. More at www.ingrammicro.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210608005190/en/
Link:
Social Media:
https://www.facebook.com/IngramMicroLatinAmericaDivision
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
